These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1836986)

  • 21. Pharmacokinetic and pharmacodynamic interactions between the ACE inhibitor cilazapril and beta-adrenoceptor antagonist propranolol in healthy subjects and in hypertensive patients.
    Belz GG; Essig J; Erb K; Breithaupt K; Hoogkamer JF; Kneer J; Kleinbloesem CH
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):317S-322S. PubMed ID: 2527545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of cilazapril in hypertensive patients with renal impairment.
    Sánchez RA; Traballi CA; Gilbert BH; Giannone CA; Long G
    J Cardiovasc Pharmacol; 1991 Feb; 17(2):222-7. PubMed ID: 1709226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of nitrendipine and cilazapril on renal hemodynamics and albuminuria in hypertensive patients with chronic renal failure.
    Kloke HJ; Wetzels JF; van Hamersvelt HW; Koene RA; Kleinbloesem CH; Huysmans FT
    J Cardiovasc Pharmacol; 1990 Dec; 16(6):924-30. PubMed ID: 1704985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of cilazapril on systolic and diastolic cardiac function in hypertensive patients.
    Schneeweiss A; Green T; Krakuer J; Goldhamer E; Szucs T; Marmor A
    J Hum Hypertens; 1989 Aug; 3(4):251-4. PubMed ID: 2529375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does the combination of cilazapril and propranolol lower blood pressure at rest and during exercise more pronouncedly than either of the two components given alone?
    Erb KA; Breithaupt K; Kleinbloesem CH; Wolf GK; Belz GG
    Clin Physiol Biochem; 1990; 8 Suppl 2():35-45. PubMed ID: 2151315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Haemodynamic and hormonal effects of cilazapril in comparison with propranolol in healthy subjects and in hypertensive patients.
    Kleinbloesem CH; Erb K; Essig J; Breithaupt K; Belz GG
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):309S-315S. PubMed ID: 2527544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discrepancies between clinic and ambulatory blood pressure responses to cilazapril therapy.
    Lacourcière Y; Leenen F; Rangno R; Spence JD; Lenis JH; Myers MG
    Can J Cardiol; 1994; 10(6):605-10. PubMed ID: 8044721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of the efficacy of cilazapril versus cilazapril plus hydrochlorothiazide in patients with mild to moderate essential hypertension. Inhibace General Practice Study Group.
    Kellaway GS
    Eur J Clin Pharmacol; 1993; 44(4):377-9. PubMed ID: 8513849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of angiotensin-converting enzyme inhibition versus beta-adrenergic blockade on aortic stiffness in essential hypertension.
    Savolainen A; Keto P; Poutanen VP; Hekali P; Standertskjöld-Nordenstam CG; Rames A; Kupari M
    J Cardiovasc Pharmacol; 1996 Jan; 27(1):99-104. PubMed ID: 8656666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and tolerability of cilazapril in patients with essential hypertension.
    Karpov YA; Vilchinskaya MY; Sorokin EV; Podinovskaya VA
    J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S86-8. PubMed ID: 7700074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination of an ACE inhibitor and indapamide improves blood pressure control, but attenuates the beneficial effects of ACE inhibition on plasma adiponectin in patients with essential hypertension.
    Huang SS; Wu TC; Lin SJ; Chen JW
    Circ J; 2009 Dec; 73(12):2282-7. PubMed ID: 19789415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of prostaglandin inhibition by indomethacin on blood pressure and renal function in hypertensive patients treated with cilazapril.
    Kirch W; Stroemer K; Hoogkamer JF; Kleinbloesem CH
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):297S-301S. PubMed ID: 2527542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of single and consecutive doses of cilazapril and its depressor effects in patients with essential hypertension.
    Shionoiri H; Gotoh E; Miyakawa T; Takasaki I; Oda H; Ueda S; Kaneko Y
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):269S-273S. PubMed ID: 2970854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term evaluation of cilazapril in severe hypertension. Assessment of left ventricular and renal function.
    Sánchez RA; Traballi CA; Marcó EJ; Cianciulli T; Giannone CA; Ramiréz AJ
    Am J Med; 1989 Dec; 87(6B):56S-60S. PubMed ID: 2532462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of angiotensin-I response by cilazapril and its time course in normal volunteers.
    Wellstein A; Essig J; Belz GG
    Clin Pharmacol Ther; 1987 Jun; 41(6):639-44. PubMed ID: 3034469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Twenty-four-hour ambulatory noninvasive continuous finger blood pressure measurement with PORTAPRES: a new tool in cardiovascular research.
    Schmidt TF; Wittenhaus J; Steinmetz TF; Piccolo P; Lüpsen H
    J Cardiovasc Pharmacol; 1992; 19 Suppl 6():S117-45. PubMed ID: 1382159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative evaluation of the acute and chronic effects of cilazapril and hydrochlorothiazide on diastolic cardiac function in hypertensive patients.
    Schneeweiss A; Rosenthal J; Marmor A
    J Hum Hypertens; 1990 Oct; 4(5):535-9. PubMed ID: 2149388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interactions between cilazapril and propranolol in man; plasma drug concentrations, hormone and enzyme responses, haemodynamics, agonist dose-effect curves and baroreceptor reflex.
    Belz GG; Essig J; Kleinbloesem CH; Hoogkamer JF; Wiegand UW; Wellstein A
    Br J Clin Pharmacol; 1988 Nov; 26(5):547-56. PubMed ID: 2974715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparative and double-blind study of the efficacy and safety of cilazapril compared to nifedipine retard in the treatment of mild and moderate arterial hypertension].
    Velasco-Cornejo IF; Mion Júnior D; Martin LC; Tinucci T; Sampaio M; Pascoal IJ; Athanázio-Heliodoro RC; Marcondes M; Franco RJ
    Arq Bras Cardiol; 1994 Mar; 62(3):159-64. PubMed ID: 7980076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Review of studies on the clinical pharmacodynamics of cilazapril.
    Belz GG; Breithaupt K; Erb K
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S14-9. PubMed ID: 7898090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.